In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Optonol Ltd.

Division of Alcon Inc.
www.optonol.com

Latest From Optonol Ltd.

Glaucoma Devices: Progress On Multiple Fronts

Recent progress on the US regulatory front is generating renewed interest in device-based glaucoma therapies, which potentially could grow to a multibillion-dollar industry. The list of companies targeting this space continues to expand, as does the variety of potential device-based solutions: the current pipeline includes several innovative and less invasive products and technologies designed to improve surgical outcomes, a growing number of advanced drug-delivery inserts to address the patient noncompliance issue that is so common in this arena, and some unique patient monitoring devices.

Medical Device

Glaucoma: Devices Go Eye-to-Eye With Drugs

This article was adapted from "In Glaucoma, Devices Go Eye-to-Eye with Drugs," in the September 2010 issue of Start-Up.
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Ophthalmic
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Middle East
      • Israel
  • Parent & Subsidiaries
  • Alcon Inc.
  • Senior Management
  • Yaron Ira, CEO
    Dan Gazit, CFO & VP, Bus. Dev.
    Oded Nissan, VP, R&D
  • Contact Info
  • Optonol Ltd.
    Phone: (972) 2 534 9666
    Neve Ilan , 90850
    Israel
Advertisement
Advertisement
UsernamePublicRestriction

Register